» Articles » PMID: 29246897

Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease

Overview
Journal Circ Heart Fail
Date 2017 Dec 17
PMID 29246897
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonpulsatile pulmonary blood flow in Fontan circulation results in pulmonary vascular disease, but the potential relationships between pulmonary vascular resistance index (PVRI) and Fontan failure have not been studied. The objective was to determine whether the absence of subpulmonary ventricle in the Fontan circulation would make patients more vulnerable to even low-level elevations in PVRI, and when coupled with low cardiac index, this would identify patients at increased risk of Fontan failure.

Methods And Results: Two hundred sixty-one adult Fontan patients underwent cardiac catheterization; age 26±3 years, men 146 (56%), atriopulmonary Fontan 144 (55%). Patients were divided into 2 groups: those with high PVRI (>2 WU·m) and low cardiac index <2.5 L min m (group 1, n=70, 30%), and those with normal PVRI and normal cardiac index (group 2, n=182, 70%). Fontan failure was defined by the composite of all-cause mortality, listing for heart transplantation, or initiation of palliative care. There were 68 (26%) cases of Fontan failure during a mean follow-up of 8.6±2.4 years. When compared with group 2, freedom from Fontan failure was significantly lower in group 1: 66% versus 89% at 5 years. The combination of high PVRI and low cardiac index was an independent risk factor for Fontan failure (hazard ratio, 1.84; 95% confidence interval, 1.09-2.85).

Conclusions: When coupled with low cardiac index, even mild elevations in PVRI identify patients at high risk of Fontan failure. This suggests that pulmonary vascular disease is a key mechanism underlying Fontan failure and supports further studies to understand the pathophysiology and target treatments to pulmonary vascular tone in this population.

Citing Articles

Sleep disordered breathing and adult congenital heart disease.

Vakali M, Memon M, Gatzoulis M, Polkey M Int J Cardiol Congenit Heart Dis. 2024; 18:100532.

PMID: 39713231 PMC: 11657728. DOI: 10.1016/j.ijcchd.2024.100532.


Thyroid dysfunction in pediatric Fontan patients is associated with unfavorable hemodynamic status and severity of protein-losing enteropathy: A report from the Fontan care network.

Sweer J, Germund I, Khalil M, Apitz C, Ten Dam K, Wendt S Int J Cardiol Congenit Heart Dis. 2024; 13:100475.

PMID: 39712226 PMC: 11657406. DOI: 10.1016/j.ijcchd.2023.100475.


Diuretic use in the adult Fontan.

Andrade L, Ortega-Legaspi J, Awh K, Fuller S, Patel B, Tobin L Int J Cardiol Congenit Heart Dis. 2024; 8:100387.

PMID: 39712038 PMC: 11657526. DOI: 10.1016/j.ijcchd.2022.100387.


Aerobic Capacity of Adults With Fontan Palliation: Disease-Specific Reference Values and Relationship to Outcomes.

Egbe A, Ali A, Miranda W, Connolly H, Borlaug B Circ Heart Fail. 2024; 18(2):e011981.

PMID: 39648896 PMC: 11835545. DOI: 10.1161/CIRCHEARTFAILURE.124.011981.


Effects of systemic ventricular assist in failing Fontan patients: a theoretical analysis using a computational model.

Kisamori E, Kotani Y, Shishido T, Kasahara S, Shimizu S J Physiol Sci. 2024; 74(1):53.

PMID: 39488708 PMC: 11531161. DOI: 10.1186/s12576-024-00946-z.


References
1.
Mori M, Hebson C, Shioda K, Elder R, Kogon B, Rodriguez F . Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions. Congenit Heart Dis. 2016; 11(6):589-597. DOI: 10.1111/chd.12345. View

2.
Andersen U, Moller S, Bendtsen F, Henriksen J . Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique. Eur J Gastroenterol Hepatol. 2003; 15(5):503-7. DOI: 10.1097/01.meg.0000059106.41030.8e. View

3.
Hebson C, McCabe N, Elder R, Mahle W, McConnell M, Kogon B . Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol. 2013; 112(12):1943-7. PMC: 4505550. DOI: 10.1016/j.amjcard.2013.08.023. View

4.
Zongtao Y, Huishan W, Zengwei W, Hongyu Z, Minhua F, Xinmin L . Experimental study of nonpulsatile flow perfusion and structural remodeling of pulmonary microcirculation vessels. Thorac Cardiovasc Surg. 2010; 58(8):468-72. DOI: 10.1055/s-0030-1250124. View

5.
Bosch J . Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol. 2007; 41 Suppl 3:S247-53. DOI: 10.1097/MCG.0b013e3181572357. View